Fund Card

Fund Card

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

As on Jan-15-2021 change fund
16.71  down-0.21 (-1.24%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

riskometer

Investors understand that their principal will be at low risk

5-Years History
financial year2019-20202020-2021
NAV in Rs (as on 15-Jan-2021)9.9916.71
Net Assets(Rs Crores) (as on 15-Jan-2021) 170.68 459.12
Scheme Returns(%)(Absolute)-0.1069.47
B'mark Returns(%)(Absolute)-15.0284.70
Category Rank6/7532/76
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202125.1321.847.88NA
2019-2020NANA5.95-6.46
Top 10 holdings
company (%)
Dr. Reddys Laboratories Ltd.11.16 
Sun Pharmaceutical Industries...10.06 
Cipla Ltd.9.24 
Divis Laboratories Ltd.9.07 
Lupin Ltd.8.48 
Aurobindo Pharma Ltd.6.82 
Apollo Hospitals Enterprise Ltd.3.70 
Torrent Pharmaceuticals Ltd.3.38 
Biocon Ltd.3.35 
Zydus Wellness Ltd.3.15 

Category

Sector Funds

Launch Date

10-Jul-19

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

459.12

portfolio price to book value

6.07

investing style?

Large Growth

fund manager?

Dhaval Shah

inception date (regular plan)

10-Jul-19

expense ratio (regular plan) %

2.74

Alpha [%]

0.14

Beta [%]

0.46

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs83.16
Hospital & Healthcare Services9.36
Consumer Food3.15
Chemicals 2.55

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019459.12-1.475.0911.5553.16NANANA40.17BUYSIP
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,383.33-1.444.9913.7766.1821.4813.1216.4921.59BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015419.33-1.154.2112.7761.9319.119.45NA8.73BUYSIP
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005649.26-1.423.9511.7564.4016.5310.0013.3818.82BUYSIP
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,575.33-0.655.5613.8565.7715.147.9616.2315.88BUYSIP
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,043.27-1.124.2311.6673.16NANANA37.05BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,159.31-0.833.6813.4869.04NANANA26.42BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,209.93-1.983.7710.3268.85NANANA28.86BUYSIP
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201968.63-1.292.749.8256.10NANANA32.11BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974